The ZEISS At Lisa tri portfolio delivers proven trifocal technology for maximum spectacle independence.
Designed for today’s cataract patients, it provides continuous visual performance at all distances – near, intermediate, and far – under varying lighting conditions. The unique asymmetrical light distribution and pupil-independent design ensure high performing visual acuity and contrast sensitivity, even at night.
Clinical evidence from over 85 peer-reviewed publications confirms high patient satisfaction and spectacle independence above 90%. With a strong track record in diverse clinical settings, the At Lisa tri family empowers surgeons to offer patients reliable, high-quality outcomes and visual freedom.
Contact: info.au@zeiss.com
Note: Supporting documentation available upon request from ZEISS.
